A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy

Pain

Volumn 138, Issue 3, 2008, Pages 657-666

  Toth, Cory ^a   Au, Shannon ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Neuropathic pain; Peripheral neuropathy; Pharmacotherapy; Polyneuropathy

Indexed keywords

ALCOHOL; AMITRIPTYLINE; ANTICONVULSIVE AGENT; CANNABINOID DERIVATIVE; CAPSAICIN; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; NABILONE; NORTRIPTYLINE; PREGABALIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

AGED; ANALGESICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; POLYNEUROPATHIES; PROSPECTIVE STUDIES; SYNDROME;

EID: 50249106427     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.04.023     Document Type: Article

References (46)

1. Argov Z., Steiner I., and Soffer D. The yield of sural nerve biopsy in the evaluation of peripheral neuropathies. Acta Neurol Scand 79 (1989) 243-245
2. Argoff C.E., Cole B.E., Fishbain D.A., and Irving G.A. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81 (2006) S3-S11
3. Backonja M.M., and Galer B.S. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 16 (1998) 775-790
4. Bennett M.I., Smith B.H., Torrance N., and Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6 (2005) 149-158
5. Boivie J. Central pain. In: Merskey H., Loeser J.D., and Dubner R. (Eds). The paths of pain (2005), IASP Press, Seattle, WA 299-307
6. Bouhassira D., Attal N., Alchaar H., Boureau F., Brochet B., Bruxelle J., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114 (2005) 29-36
7. Breivik H., Collett B., Ventafridda V., Cohen R., and Gallacher D. Survey of chronic pain in Europe. Prevalence, impact on daily life, and treatment. Eur J Pain 10 (2006) 287-333
8. Bril V., and Perkins B.A. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25 (2002) 2048-2052
9. Burns T.L., and Ineck J.R. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. Ann Pharmacother 40 (2006) 251-260
10. Campbell J.N., Raja S.N., Meyer R.A., and MacKinnon S.E. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32 (1988) 89-94
11. Campbell J.N., and Meyer R.A. Mechanisms of neuropathic pain. Neuron 52 (2006) 77-92
12. Chen H., Lamer T.J., Rho R.H., Marshall K.A., Sitzman B.T., Ghazi S.M., et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 79 (2004) 1533-1545
13. Collins S.D., and Chessell I.P. Emerging therapies for neuropathic pain. Expert Opin Emerg Drugs 10 (2005) 95-108
14. Cook R.J., and Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 310 (1995) 452-454
15. Daousi C., MacFarlane I.A., Woodward A., Nurmikko T.J., Bundred P.E., and Benbow S.J. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 21 (2004) 976-982
16. Dyck P.J., Oviatt K.F., and Lambert E.H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 10 (1981) 222-226
17. Dyck P.J., Sherman W.R., Hallcher L.M., Service F.J., O'Brien P.C., Grina L.A., et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 8 (1980) 590-596
18. Elliott A.M., Smith B.H., Penny K.I., Smith W.C., and Chambers W.A. The epidemiology of chronic pain in the community. Lancet 354 (1999) 1248-1252
19. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 (2005) 1324-1334
20. Gilron I., and Max M.B. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 5 (2005) 823-830
21. Gore M., Brandenburg N.A., Hoffman D.L., Tai K.S., and Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 7 (2006) 892-900
22. Harstall C., and Ospina M. Prevalence of chronic pain. In: Carr D. (Ed). Clinical updates vol. 11 (2003), IASP Press, Seattle, WA 2
23. Herrmann D.N., Barbano R.L., Hart-Gouleau S., Pennella-Vaughan J., and Dworkin R.H. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 6 (2005) 379-384
24. Horowitz S.H. Criteria for the diagnosis of peripheral neuropathies. Occup Environ Med 59 (2002) 425-426
25. Hughes R.A. Peripheral neuropathy. BMJ 324 (2002) 466-469
26. Koike H., Mori K., Misu K., Hattori N., Ito H., Hirayama M., et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 56 (2001) 1727-1732
27. Martyn C.N., and Hughes R.A.C. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 62 (1997) 310-318
28. Merskey H., and Bogduk N. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms (1994), IASP Press, Seattle, WA p. 209-213
29. Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Brain Behav Immun 2006 [Epub ahead of print].
30. Morello C.M., Leckband S.G., Stoner C.P., Moorhouse D.F., and Sahagian G.A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159 (1999) 1931-1937
31. Moulin D.E., Clark A.J., Gilron I., Ware M.A., Watson C.P., Sessle B.J., et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12 (2007) 13-21
32. Namaka M., Gramlich C.R., Ruhlen D., Melanson M., Sutton I., and Major J. A treatment algorithm for neuropathic pain. Clin Ther 26 (2004) 951-979
33. Notermans N.C., Wokke J.H.J., Van der Graaf Y., Franssen H., Van Dijk G.W., and Jennekens F.G.I. Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 57 (1994) 1525-1527
34. Notermans N.C., Wokke J.H., Franssen H., van der Graaf Y., Vermeulen M., van den Berg L.H., et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 56 (1993) 1066-1071
35. Pandey C.K., Bose N., Garg G., Singh N., Baronia A., Agarwal A., et al. Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg 95 (2002) 1719-1723
36. Perkins B.A., Olaleye D., Zinman B., and Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 24 (2001) 250-256
37. Prineas J. Polyneuropathies of undetermined cause. Acta Neurol Scand Suppl 44 (1970) 3-72
38. Rudolph T., and Farbu E. Hospital-referred polyneuropathies - causes, prevalences, clinical and neurophysiological findings. Eur J Neurol 14 (2007) 603-608
39. Scadding J.W., and Koltzenburg M. Painful peripheral neuropathies. In: McMahon S.B., and Koltzenburg M. (Eds). Wall and Melzack's textbook of pain (2006), Elsevier, London 973-999
40. Spruce M.C., Potter J., and Coppini D.V. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med 20 (2003) 88-98
41. Taylor R. Epidemiology of refractory neuropathic pain. Pain Pract 6 (2006) 22-26
42. Torebjork H., Lundberg L., and LaMotte R. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond) 448 (1992) 765-780
43. Torrance N., Smith B.H., Bennett M.I., and Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7 (2006) 281-289
44. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology 2007 [Epub ahead of print].
45. Verghese J., Bieri P.L., Gellido C., Schaumburg H.H., and Herskovitz S. Peripheral neuropathy in young-old and old-old patients. Muscle Nerve 24 (2001) 1476-1481
46. Wolfe G.I., Baker N.S., Amato A.A., Jackson C.E., Nations S.P., Saperstein D.S., et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 56 (1999) 540-547